Journal of Lower Genital Tract Disease

Journal of Lower Genital Tract Disease is the official journal of the American Society for Colposcopy and Cervical Pathology, known as ASCCP, and Lippincott Williams & Wilkins has published it since 1997.《Journal of Lower Genital Tract Disease》是美国阴道镜与宫颈病理学会（ASCCP）的机关刊，自 1997 年起由 Lippincott Williams & Wilkins 出版。

The society's stated mission for the journal is to promote excellence in the care of people with anogenital and HPV-related disease, to keep clinicians well informed and to raise the standards of research conduct and reporting.学会为这本刊定下的使命是推动肛门生殖器与 HPV 相关疾病的诊疗水平，让临床医生保持知情，并提高研究实施与报告的标准。

The 2025 impact factor is 2.3 and the five-year figure 3.4. In obstetrics and gynecology it ranks 60th of 143 titles, and the file carries 2,228 citations.2025 年影响因子 2.3，五年值 3.4。在妇产科类 143 种刊里排第 60 位，名下累计被引 2,228 次。

Scope

• The organ in the title is the limit. Work on the lower genital tract of either gender belongs here, and the upper tract does not.刊名里的器官就是边界。不论男女，下生殖道的稿件归这里，上生殖道的不归。

• That exclusion is spelled out. Papers on the uterus, the fallopian tubes and the ovaries, on maternal and fetal topics, or on infertility without a lower tract focus are redirected to other journals.这条界限写得很明确。子宫、输卵管、卵巢的稿子，母胎题目的稿子，以及不以下生殖道为落点的生育问题，都被劝投他刊。

• HPV is the spine of the file, from primary screening and genotyping through triage of abnormal results to the follow-up interval after treatment.HPV 是整份档案的主轴，从初筛与分型，到异常结果的分流，再到治疗后的随访间隔。

• Non-HPV conditions carry equal weight. Vulvar lichen sclerosus, lichen planus, chronic vulvovaginal pain and the dermatoses that imitate them appear as often as viral work.非 HPV 的病症分量相当。外阴硬化性苔藓、扁平苔藓、慢性外阴阴道疼痛，以及与之混淆的皮肤病，出现频率不亚于病毒方面的研究。

• Anorectal disease has its own steady presence, which is why anal cytology, high-grade lesions in men who have sex with men and the follow-up of HIV-positive patients recur through the volumes.肛门直肠疾病长期占一席，肛管细胞学、男男性行为者中的高级别病变，以及 HIV 阳性人群的随访，在各卷里反复出现。

• Underserved populations are named in the aims as a welcome subject, so screening coverage in low-resource settings and the barriers that keep women away from colposcopy qualify on their own.宗旨里点名欢迎资源匮乏人群的研究，低资源环境下筛查覆盖率、妨碍女性接受阴道镜检查的障碍，本身就算合格的选题。

• Study designs are laid out in the aims: treatment, prevention, diagnosis, screening, quality of life, genetics and epidemiology, with original research in both basic science and clinical practice.宗旨把研究类型列了个遍，治疗、预防、诊断、筛查、生活质量、遗传与流行病学，基础研究与临床实践的原创稿都在内。

• Clinical trials are filtered hard. Apart from exceptional cases, the journal takes only randomized, placebo-controlled trials, so a single-arm series is not enough to claim an effect.临床试验筛得很严。除了个别例外，刊物只收随机、安慰剂对照的试验，单臂系列不足以支撑疗效结论。

• Original research runs to 3,000 words with six tables or figures and 30 references, and the abstract may not exceed 250 words.原创研究上限 3,000 词，图表 6 个，参考文献 30 条，摘要不超过 250 词。

• Case reports are admitted but rarely. The limit is 750 words, three tables or figures and eight references, and the editors ask authors to follow the CARE reporting guideline.病例报告收，但很少。上限 750 词、3 个图表、8 条参考文献，编辑要求作者按 CARE 报告规范来写。

• Systematic reviews, meta-analyses, guidelines and decision aids get 3,500 words and six tables or figures, with references counted as the studies plus twelve.系统综述、荟萃分析、指南与决策辅助工具给 3,500 词、6 个图表，参考文献按纳入研究数另加 12 条计。

• Every article opens with a précis of no more than 25 words, and the discussion with its conclusions is asked to stay under 1,200 words, so the argument has to be made early.每篇文章开头附一段不超过 25 词的提要，讨论与结论被要求压在 1,200 词以内，论证必须早早在前面立住。

• Reporting guidelines are mandated rather than suggested. CONSORT and its extensions, the STROBE family, CHEERS, STARD, PRISMA and MOOSE each have a stated place.报告规范是强制而非建议。CONSORT 及其扩展、STROBE 系列、CHEERS、STARD、PRISMA 与 MOOSE 各有指定的位置。

• A vulva and vagina section runs as a distinct block of content, which is unusual in a field where the cervix usually takes the whole agenda.外阴与阴道自成一栏内容，这样的安排在宫颈通常占满议程的领域里并不常见。

History

• The first volume is dated 1997, and the publisher of record then was Blackwell Science, working out of Malden, Massachusetts.第 1 卷署 1997 年，当时的出版方是 Blackwell Science，办公地在马萨诸塞州的马尔登。

• The launch editorial took the Papanicolaou smear as its subject and called it medicine's most successful cancer-screening procedure, a claim that set the tone for the journal.创刊社论拿巴氏涂片做题目，称之为医学史上最成功的癌症筛查手段，这句话定下了刊物的调子。^[1]

• Five years in, the title changed hands. By 2002 the imprint had moved to Hagerstown, Maryland, under Lippincott Williams & Wilkins, which is where it has stayed.办了五年，刊物换了东家。到 2002 年，出版地记录已经改到马里兰州的黑格斯敦，由 Lippincott Williams & Wilkins 承接，此后没有再变。

• Volume numbering starts with the founding year, so 1997 is volume 1 and 2026 is volume 30. Four issues make a volume and supplements are numbered inside the year.卷号从创刊年起算，1997 年是第 1 卷，2026 年是第 30 卷。一卷 4 期，增刊在当年卷内编号。

• MEDLINE and PubMed picked the journal up late, at volume 9, number 1, in January 2005, so the first eight volumes exist in print and online without being indexed.MEDLINE 与 PubMed 收得晚，从 2005 年 1 月的第 9 卷第 1 期才开始，前八卷只有印刷本与在线全文，不在索引里。

• Five impact factors read 1.925, 3.842, 2.4, 2.1 and 2.3. The 2022 spike was more than double the year before it and lasted a single filing.五个影响因子依次是 1.925、3.842、2.4、2.1、2.3。2022 年的尖峰比前一年翻了一倍多，只维持了一次统计。

• The 2025 file credits 2,228 citations to 61 articles in the year, gives a cited half-life of six years and a JCI of 0.96.2025 年的表记下 2,228 次引用对当年 61 篇文章，被引半衰期 6 年，JCI 0.96。

• Sixty-one articles a year across four issues means roughly fifteen papers per issue, which leaves room for commentary, correspondence and the occasional review.一年 4 期 61 篇，平均每期十五篇上下，剩下的版面留给评论、通讯与偶见的综述。

• Gold open access covers 20 percent of the file, a share well above the specialty average, and the rest sits behind the subscription wall.金色开放获取占全部文章的 20%，高于本学科的一般水平，其余仍在订阅墙之内。

• DOI strings still carry the original publisher's numbering in the founding volumes, a fossil of the Blackwell years that resolves under the current Lippincott prefix.创刊各卷的 DOI 仍带着原出版方的编号方式，那是 Blackwell 时期留下的化石，如今在 Lippincott 的前缀下解析。

• The society behind it has kept a separate public role, publishing management guidelines and a mobile app for cervical cancer screening alongside the journal.背后的学会另有一条公共线，除刊物之外还发布宫颈癌筛查的管理指南，并为此做了一个手机应用。

Editors

• In October 2021 Bar-Ilan University announced that Jacob Bornstein, of its Azrieli Faculty of Medicine, had been appointed editor-in-chief of the journal.2021 年 10 月，巴伊兰大学（Bar-Ilan University）宣布，该校 Azrieli 医学院的 Jacob Bornstein 被任命为这本刊的主编。

• Israeli medical coverage of the appointment singled out one detail: he was the first editor-in-chief of the journal to come from outside the United States.以色列的医学媒体报道这项任命时专门点出一件事，他是这本刊首位来自美国之外的主编。

• The journal had been edited from North America for its first twenty-five years, in step with a society whose membership was concentrated there.头二十五年，刊物的编辑工作都在北美，与会员集中在那里的学会同步。

• Review turned double anonymized in January 2022. Authors submit a title page separate from an anonymized manuscript, so neither side learns the other's identity.2022 年 1 月起，评审改为双盲。作者须把题名页与匿名化的正文分开提交，双方都不知道对方是谁。^[1]

• Editorials are written in house by the editor-in-chief or the senior editors and are signed, which makes them the journal's own voice rather than a slot for outside opinion.社论由主编或资深编辑在编辑部内部撰写并署名，因此是刊物自己的声音，不是给外部意见留的窗口。

• Commentary is usually invited, and review articles come the same way, so most of the reflective content is commissioned before it is written.评论通常靠约稿，综述也走同一条路，因此多数思辨性内容在动笔之前就已定下。

• Authors must state in the methods section how any generative tool was used, and claims that a case is the first reported one are not accepted as a reason to publish.作者须在方法部分说明生成式工具的用法，仅凭「首次报告」这一条不足以成为发表理由。

• Submissions run through Editorial Manager, and the manuscript has to carry line numbers, six to ten MeSH keywords and a graphical or video abstract if the authors choose to supply one.投稿走 Editorial Manager，正文必须带行号，附 6 至 10 个 MeSH 关键词，作者也可另交图文摘要或视频摘要。

• The editorial line quotes the ICMJE recommendations and COPE, and the journal's own pages put the two together as the standard it holds authors and reviewers to.编辑方针同时援引 ICMJE 建议与 COPE，刊方把两者并列为对作者与审稿人的要求。